End-of-day quote
Other stock markets
|
||
- USD | - |
Jun. 28 | Savara Prices $100 Million Common Shares Offering | MT |
Jun. 27 | JMP Securities Adjusts Price Target on Savara to $10 From $8, Maintains Market Outperform Rating | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pauls
CEO | Chief Executive Officer | 53 | 17-04-26 |
David Lowrance
DFI | Director of Finance/CFO | 56 | 17-04-26 |
Robert Lutz
COO | Chief Operating Officer | 55 | 23-02-12 |
Raymond Pratt
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-11-09 |
Anne Erickson
IRC | Investor Relations Contact | 52 | 18-09-30 |
Charles LaPree
LAW | General Counsel | - | 21-07-31 |
Kate McCabe
LAW | General Counsel | - | 18-02-28 |
Scott Wilhoit
PRN | Corporate Officer/Principal | 61 | 23-01-08 |
Peter M. Clarke
PRN | Corporate Officer/Principal | 64 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ramsay
BRD | Director/Board Member | 59 | 17-04-26 |
Richard Hawkins
BRD | Director/Board Member | 74 | 10-09-30 |
Nevan Elam
BRD | Director/Board Member | 56 | 09-01-31 |
Joseph McCracken
BRD | Director/Board Member | 70 | 17-04-26 |
Matthew Pauls
CEO | Chief Executive Officer | 53 | 17-04-26 |
Director/Board Member | 64 | 19-12-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 164,423,361 | 156,646,102 ( 95.27 %) | 0 | 95.27 % |
Company contact information
Savara, Inc.
1717 Langhorne Newtown Road Suite 302
19047, Langhorne
+(512) 614-1848
http://www.savarapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- SVRA Stock
- Stock
- Company Savara Inc